TORONTO, ONTARIO--(Marketwire - November 28, 2007) - Cannasat Therapeutics Inc. (TSX VENTURE: CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the nine months ended September 30, 2007.
TORONTO, ONTARIO--(Marketwire - November 28, 2007) - Cannasat Therapeutics Inc. (TSX VENTURE: CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the nine months ended September 30, 2007.
